Napp Pharmaceuticals Limited

Cambridge Science Park, Milton Road, Cambridge, Cambridgeshire, CB4 0GW
Telephone: +44 (0)1223 424 444
Fax: +44 (0)1223 424 441
WWW: http://www.napp.co.uk
Medical Information Fax: +44 (0)1223 424 912

Patient Information Leaflet last updated on the eMC: 14/06/2011
PIL OxyContin tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 14/06/2011 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to information about drinking alcohol
Updated on 18/08/2010 and displayed until 14/06/2011
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to information about drinking alcohol
Updated on 02/07/2010 and displayed until 18/08/2010
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 22/12/2009 and displayed until 02/07/2010
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 24/05/2004 and displayed until 22/12/2009
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to, or new, use for medicine
  • Change to date of revision
  • Change to side-effects
Updated on 20/01/2003 and displayed until 24/05/2004
Reasons for adding or updating:
  • Update to PIL
Updated on 10/06/2002 and displayed until 20/01/2003
Reasons for adding or updating:
  • Update to PIL
Updated on 04/02/2002 and displayed until 10/06/2002
Reasons for adding or updating:
  • Update to PIL
Updated on 13/09/2000 and displayed until 04/02/2002
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   oxycodone hydrochloride